Summary
Novavax , Inc.
Founded in 1995
Description
Novavax is a biotech company that develops and produces recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. They use innovative vaccine technology, including recombinant nanoparticle technology, to create transfor...
Strengths
- Novavax , Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- Since Novavax , Inc. was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- The number of employees is not growing as fast as the industry average
Annual Revenue
Novavax , Inc.'s annual revenue
$2387715000
Based on Kona Equity data
-
Revenue per employee
$1591810
-
Annual revenue growth since founding
$82335000
-
Revenue growth rate from first known quarter to current
10.0%
Employee Count
1500 employees
-
Employee growth rate from first known quarter to current
-51.6%
Executives
Gregory Glenn
President, Research & Development
g**@novavax.comLarry Mccallum
Vice President, Internal Communications
l**@novavax.comLee Biegie
Vice President, Information Technology
l**@novavax.comAngela Lee
Director, Data Management
a**@novavax.comMeyer Gladstone
Senior Director, Customer Marketing
m**@novavax.comTracy Huff
Senior HR Business Partner
t**@novavax.comFilip Dubovsky
Chief Medical Officer
f**@novavax.comJohn Trizzino
Executive VP, Chief Commercial Officer & Chief Business Officer
j**@novavax.comKomlanvi Gbete
Lab, Lab Support Technician
k**@novavax.comFernando Maeda
Scientist 1
f**@novavax.comFarai Sikipa
Associate Director, Multi-Channel & Digital Marketing
f**@novavax.comTroy Cool
Senior Scheduler and Planner
t**@novavax.comJill Hoyt
Executive VP & Chief Human Resources Officer
j**@novavax.comJessica Keliher
Director, Senior Human Resource Business Partner
j**@novavax.comRichard Crowley
Executive VP & Chief Operations Officer
r**@novavax.comStanley Erck
CEO
s**@novavax.comWayne Meitin
Vice President, Trade & Distribution
w**@novavax.comSilvia Uranova
Global Senior VP, Corporate Affairs & Investor Relations
s**@novavax.comPeter Janiszewski
Analytical Development Associate Scientist
p**@novavax.comOctavia Harrison
QA Operations QA Specialist IV
o**@novavax.comBetty Rhiew
Vice President, Marketing
b**@novavax.comSean Robine
Manager, Talent Acquisition Operations
s**@novavax.comStephanie Garcia
Global Vice President, Quality Assurance
s**@novavax.comTroy Morgan
Chief Compliance Officer
t**@novavax.comKim Denny
Senior Vice President, Chief Safety Officer
k**@novavax.comHansu Dong
Executive Director, Clinical Outsourcing & Business Operations
h**@novavax.comRaj Sharma
Chief Information Security Officer
r**@novavax.comRobert Jannelle
Director, Quality Assurance
r**@novavax.comKathleen Callahan
Vice President, Regulatory Affairs
k**@novavax.comKimberly Diaz
Vice President, Sales Operations
k**@novavax.comJim Kelly
Executive Vice President & Chief Financial Officer
j**@novavax.comDenny Kim
Senior Vice President, Chief Safety Officer
d**@novavax.comPhone Novavax
President & Chief Executive Officer
p**@novavax.comG Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
192 K
-
Page views per visitor
2.1
-
Daily time
3:47
-
Bounce Rate
37.4 %
Location
Unlock unlimited leads
Similar Companies
Atara Bio
atarabio.com- Founded in 2012
- Location: South San Francisco, CA
- Annual Revenue: $70.9M
- Employees: 334
- Atara Biotherapeutics is a leading off the shelf, allogeneic T cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara Biotherapeutics develops next gen CART therapies & off the shelf allog...
Vir Biotechnology, Inc.
vir.bio- Founded in 2008
- Location: San Francisco, CA
- Annual Revenue: $427.2M
- Employees: 576
- Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Inovio Pharmaceuticals , Inc.
inovio.com- Founded in 1979
- Location: Plymouth Meeting, PA
- Annual Revenue: $10.3M
- Employees: 184
- INOVIO Pharmaceuticals is a clinical stage pharmaceutical company that is developing DNA immunotherapies and vaccines to treat and prevent cancers and infectious diseases. Their DNA medicines are designed DNA plasmids delivered through their proprietar...
Dynavax Technologies Corporation
dynavax.com- Location: Emeryville, CA
- Annual Revenue: $459.4M
- Employees: 351
- Dynavax Technologies is focused on leveraging the power of the bodys innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
NGM Bio
ngmbio.com- Founded in 2008
- Location: South San Francisco, CA
- Annual Revenue: $77.3M
- Employees: 225
- NGM Bio is a biopharmaceutical company that is focused on harnessing powerful human biology to develop transformative therapeutics for patients. They have a broad and diverse pipeline of novel medicines that target a range of therapeutic areas and dise...
Clover Biopharmaceuticals
cloverbiopharma.com- Founded in 2007
- Location: Boston, MA
- Annual Revenue: $50.7M
- Employees: 83
- Our mission is to leverage our Trimer-Tag technology and in-house manufacturing capabilities for the discovery, development and delivery of innovative and affordable medical solutions.
Key Information
- Name: Novavax , Inc.
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 48; 4883
See similar companies
-
By City Gaithersburg Small Biotechnology Company in Gaithersburg Mid-size Biotechnology Company in Gaithersburg Pharmaceuticals in Gaithersburg Small Pharmaceuticals in Gaithersburg Mid-size Pharmaceuticals in Gaithersburg
-
By State MD Small companies in MD Pharmaceuticals in MD Small Pharmaceuticals in MD Mid-size Pharmaceuticals in MD Small Biotechnology Company in MD Mid-size Biotechnology Company in MD
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 5 Founded in 1995 SIC: 87 SIC: 873 NAICS: 48 NAICS: 4883 #Business Services General #Business Services #Organizations General #Education General #Education #Organizations
Frequently Asked Questions
Novavax , Inc.'s headquarters are located at 21 Firstfield Rd. Gaithersburg, MD 20878.
Novavax , Inc.'s official website is novavax.com
Novavax , Inc.'s annual revenue is $2.4 B.
Novavax , Inc.'s SIC: 87; 873
Novavax , Inc.'s NAICS: 48; 4883.
Novavax , Inc. has 1500 employees
Novavax , Inc. is in the industry of Pharmaceuticals.
